China Medical System Holdings Limited (0867.HK)
HKD 7.36
(-0.67%)
HKD 7.36
(-0.67%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -3 Billion CNY | -17.38% |
| 2022 | -2.56 Billion CNY | -53.2% |
| 2021 | -1.67 Billion CNY | 19.09% |
| 2020 | -2.06 Billion CNY | -217.6% |
| 2019 | -651.22 Million CNY | -200.17% |
| 2018 | 650.11 Million CNY | -47.97% |
| 2017 | 1.24 Billion CNY | 10.57% |
| 2016 | 1.12 Billion CNY | 2632.78% |
| 2015 | -44.61 Million CNY | -118.53% |
| 2014 | 240.72 Million CNY | 239.33% |
| 2013 | -172.77 Million CNY | 34.59% |
| 2012 | -264.13 Million CNY | 56.84% |
| 2011 | -612.05 Million CNY | 31.27% |
| 2010 | -890.46 Million CNY | -703.19% |
| 2009 | -110.86 Million CNY | 23.22% |
| 2008 | -144.39 Million CNY | -12.3% |
| 2007 | -128.57 Million CNY | -216.56% |
| 2006 | -40.61 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -2.8 Billion CNY | 1.26% |
| 2024 Q1 | -2.8 Billion CNY | 6.69% |
| 2023 Q4 | -3 Billion CNY | -0.06% |
| 2023 Q2 | -3.12 Billion CNY | 0.47% |
| 2023 FY | -3 Billion CNY | -17.38% |
| 2023 Q1 | -3.14 Billion CNY | -22.62% |
| 2023 Q3 | -3 Billion CNY | 3.88% |
| 2022 FY | -2.56 Billion CNY | -53.2% |
| 2022 Q4 | -2.56 Billion CNY | 0.61% |
| 2022 Q3 | -2.57 Billion CNY | -16.39% |
| 2022 Q2 | -2.21 Billion CNY | 0.6% |
| 2022 Q1 | -2.22 Billion CNY | -33.24% |
| 2021 Q3 | -1.68 Billion CNY | 22.88% |
| 2021 Q4 | -1.67 Billion CNY | 0.89% |
| 2021 Q2 | -2.18 Billion CNY | 0.05% |
| 2021 FY | -1.67 Billion CNY | 19.09% |
| 2021 Q1 | -2.19 Billion CNY | -5.9% |
| 2020 Q3 | -2.06 Billion CNY | -47.07% |
| 2020 Q2 | -1.4 Billion CNY | -0.05% |
| 2020 Q1 | -1.4 Billion CNY | -115.99% |
| 2020 Q4 | -2.06 Billion CNY | 0.07% |
| 2020 FY | -2.06 Billion CNY | -217.6% |
| 2019 Q2 | -195.16 Million CNY | 0.0% |
| 2019 Q1 | -195.16 Million CNY | -130.02% |
| 2019 FY | -651.22 Million CNY | -200.17% |
| 2019 Q4 | -651.22 Million CNY | 1.4% |
| 2019 Q3 | -660.46 Million CNY | -238.41% |
| 2018 Q1 | 663.3 Million CNY | -46.91% |
| 2018 Q2 | 663.3 Million CNY | 0.0% |
| 2018 Q3 | 650.11 Million CNY | -1.99% |
| 2018 Q4 | 650.11 Million CNY | 0.0% |
| 2018 FY | 650.11 Million CNY | -47.97% |
| 2017 Q1 | 2.51 Billion CNY | 122.75% |
| 2017 Q4 | 1.24 Billion CNY | 0.0% |
| 2017 Q3 | 1.24 Billion CNY | -50.36% |
| 2017 Q2 | 2.51 Billion CNY | 0.0% |
| 2017 FY | 1.24 Billion CNY | 10.57% |
| 2016 Q3 | 1.12 Billion CNY | -18.82% |
| 2016 Q2 | 1.39 Billion CNY | 0.0% |
| 2016 FY | 1.12 Billion CNY | 2632.78% |
| 2016 Q1 | 1.39 Billion CNY | 3219.95% |
| 2016 Q4 | 1.12 Billion CNY | 0.0% |
| 2015 Q4 | -44.61 Million CNY | -119.02% |
| 2015 FY | -44.61 Million CNY | -118.53% |
| 2015 Q3 | 234.56 Million CNY | 126.88% |
| 2015 Q2 | 103.38 Million CNY | 0.0% |
| 2015 Q1 | 103.38 Million CNY | -57.05% |
| 2014 FY | 240.72 Million CNY | 239.33% |
| 2014 Q4 | 240.72 Million CNY | 0.0% |
| 2014 Q3 | 240.72 Million CNY | 149.22% |
| 2014 Q2 | -489.11 Million CNY | 0.0% |
| 2014 Q1 | -489.11 Million CNY | -183.09% |
| 2013 Q4 | -172.77 Million CNY | 0.6% |
| 2013 FY | -172.77 Million CNY | 34.59% |
| 2013 Q1 | -181.92 Million CNY | 31.13% |
| 2013 Q2 | -180.42 Million CNY | 0.82% |
| 2013 Q3 | -173.82 Million CNY | 3.66% |
| 2012 Q2 | -688.81 Million CNY | 19.72% |
| 2012 Q4 | -264.13 Million CNY | 60.8% |
| 2012 Q3 | -673.77 Million CNY | 2.18% |
| 2012 FY | -264.13 Million CNY | 56.84% |
| 2012 Q1 | -858.04 Million CNY | -40.19% |
| 2011 FY | -612.05 Million CNY | 31.27% |
| 2011 Q4 | -612.05 Million CNY | 0.0% |
| 2011 Q2 | -490.08 Million CNY | 0.0% |
| 2010 Q2 | -80.25 Million CNY | 0.0% |
| 2010 FY | -890.46 Million CNY | -703.19% |
| 2010 Q4 | -890.46 Million CNY | 0.0% |
| 2009 Q4 | -110.86 Million CNY | 0.0% |
| 2009 FY | -110.86 Million CNY | 23.22% |
| 2008 FY | -144.39 Million CNY | -12.3% |
| 2007 FY | -128.57 Million CNY | -216.56% |
| 2006 FY | -40.61 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | -258.7 Million HKD | -1063.234% |
| Grand Pharmaceutical Group Limited | 2.03 Billion HKD | 248.107% |
| Extrawell Pharmaceutical Holdings Limited | 5.94 Million HKD | 50727.877% |
| Wai Yuen Tong Medicine Holdings Limited | 301.53 Million HKD | 1097.997% |
| Qianhai Health Holdings Limited | -19.03 Million HKD | -15706.918% |
| Lee's Pharmaceutical Holdings Limited | 30.94 Million HKD | 9823.798% |
| Essex Bio-Technology Limited | -219.22 Million HKD | -1272.684% |
| Tongfang Kontafarma Holdings Limited | 256.16 Million HKD | 1274.763% |
| PuraPharm Corporation Limited | 377.54 Million HKD | 897.068% |
| SSY Group Limited | 1.71 Billion HKD | 275.622% |
| JBM (Healthcare) Limited | -7.39 Million HKD | -40571.996% |
| Jacobson Pharma Corporation Limited | 337.44 Million HKD | 991.804% |
| China Resources Pharmaceutical Group Limited | 50.97 Billion HKD | 105.903% |